Cargando…
Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis
Immunophenotyping is critical to the diagnosis of MS, as it can be difficult to differentiate from other diagnoses including lymphoma using conventional light microscopy.
Autores principales: | Trennepohl, Christopher, Sorah, Jonathan, Eulitt, Patrick, Galeotti, Jonathan, Zeidner, Joshua F., Montgomery, Nathan D., Coombs, Catherine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878033/ https://www.ncbi.nlm.nih.gov/pubmed/31788302 http://dx.doi.org/10.1002/ccr3.2473 |
Ejemplares similares
-
Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 BCR-ABL1 Fusion Transcript
por: Sheets, Julia W., et al.
Publicado: (2020) -
Generalized lymphadenopathy secondary to isolated extramedullary hematopoiesis as an initial manifestation of primary myelofibrosis
por: Aljabry, Mansour S., et al.
Publicado: (2018) -
Clinical and molecular features of
FLT3
juxtamembrane domain missense mutations in acute myeloid leukaemia
por: Jensen, Christopher E., et al.
Publicado: (2022) -
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
por: Johnson, Steven M., et al.
Publicado: (2023) -
Kikuchi–Fujimoto disease manifesting bilateral lymphadenopathy
por: Kawatsuki, Akihiro, et al.
Publicado: (2022)